BATON ROUGE, La., Dec. 17, 2012 /PRNewswire/ -- Albemarle Corporation (NYSE: ALB), a global developer, manufacturer and marketer of highly engineered specialty chemicals, announced today that it will increase global prices for its line of WELLBROM® clear brine fluids by 15%. The price increases are effective immediately, or as contracts allow, on the following products:
- WELLBROM® sodium bromide fluid
- WELLBROM® calcium bromide fluid
- WELLBROM® zinc bromide/calcium bromide fluid
Albemarle's clear brine fluids are part of the company's Performance Chemicals division within the Fine Chemistry business segment. These products provide high value in oilfield, clean energy, water treatment and other applications.
Albemarle Corporation, headquartered in Baton Rouge, Louisiana, is a leading global developer, manufacturer, and marketer of highly-engineered specialty chemicals for consumer electronics, petroleum refining, utilities, packaging, construction, automotive/transportation, pharmaceuticals, crop protection, food-safety and custom chemistry services. Albemarle is committed to global sustainability and is advancing its eco-practices and solutions in its three business segments, Polymer Solutions, Catalysts and Fine Chemistry. Corporate Responsibility Magazine selected Albemarle to its prestigious "100 Best Corporate Citizens" list for 2010 and 2011. Albemarle employs approximately 4,000 people and serves customers in approximately 100 countries. Albemarle regularly posts information to www.albemarle.com, including notification of events, news, financial performance, investor presentations and webcasts, Regulation G reconciliations, SEC filings, and other information regarding the Company, its businesses and the markets we serve.
"Safe Harbor" Statement under the Private Securities Litigation Reform Act of 1995: Statements in this press release regarding Albemarle Corporation's business that are not historical facts are "forward-looking statements" that involve risks and uncertainties. For a discussion of such risks and uncertainties, which could cause actual results to differ from those contained in the forward-looking statements, see "Risk Factors" in the Company's Annual Report on Form 10-K.
SOURCE Albemarle Corporation
Ashley Mendoza, +1-225-388-7137, Ashley.Mendoza@albemarle.com; or Investor Relations Contact, Lorin Crenshaw, +1-225-388-7322, Lorin.Crenshaw@albemarle.com